(Q50558927)

English

Intravitreal bevacizumab alone versus in combination with photodynamic therapy for the treatment of neovascular maculopathy in patients aged 50 years or older: 1-year results of a prospective clinical study.

scientific article published on 16 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

Intravitreal bevacizumab alone versus in combination with photodynamic therapy for the treatment of neovascular maculopathy in patients aged 50 years or older: 1-year results of a prospective clinical study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

1 reference

based on heuristic

inferred from title

author name string

Jong Yoon Lim

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

Sun Young Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

June-Gone Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

Joo Yong Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

Hyewon Chung

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

Young Hee Yoon

6

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

publication date

16 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

Acta Ophthalmologica

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

90

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

61-67

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

Prevalence of age-related macular degeneration in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

Polypoidal choroidal vasculopathy: natural history

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01841.X

21 January 2018

Identifiers

10.1111/J.1755-3768.2009.01841.X

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/20337606

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50558927&oldid=1189769980"